Loading...

(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) are a response to EGFR-tyrosine kinase inhibitor. However, a lack of sufficient tumor tissue has been a limitation for determining EGFR mutation status in clinical practice. The objective of this study was to pre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Guan, Jian, Xiao, Nan J., Chen, Min, Zhou, Wen L., Zhang, Yao W., Wang, Shuang, Dai, Yong M., Li, Lu, Zhang, Yue, Li, Qin Y., Li, Xiang Z., Yang, Mi, Wu, Hu B., Chen, Long H., Liu, Lai Y.
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5265876/
https://ncbi.nlm.nih.gov/pubmed/27472739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000004421
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!